Follow Tom On:
Categories
-
Recent Posts
- Linking To PedsCases Note (Infographic) “Cystic Fibrosis”
- Linking To And Excerpting From PedsCases’ “Cystic Fibrosis: Classic Presentation (Part 2 of 2)”
- Linking To And Excerpting From PedsCases’ “Cystic Fibrosis: Early Presentation (Part 1 of 2)”
- Linking To And Excerpting From “TOWARD, a metabolic health intervention, demonstrates robust 1-year weight loss and cost-savings through deprescription”
- Linking To And Embedding Dr. Josef’s “Mental illness: is keto the answer?”
- Linking To And Embedding Metabolic Mind’s “10 Essential Keys to Using Ketogenic Therapy for Mental Health”
- Linking To And Embedding Metabolic Mind’s “Unlocking Mental Health with Ketogenic Therapy: A Beginner’s Guide” With An Additional Link
- Linking To And Excerpting From The American Society Of Echocardiography’s “Non-Invasive Imaging in Coronary Syndromes”
- Linking To And Excerpting From The American Society Of Echocardiography’s “Recommendations for the Assessment of Carotid Arterial Plaque by Ultrasound for the Characterization of Atherosclerosis and Evaluation of Cardiovascular Risk: From the American Society of Echocardiography”
- Linking To And Excerpting From The Mass General Brigham Newsroom’s “Weight Loss Drugs And Blindness:
- Linking To And Embedding Dr. Kevin Joseph’s “Dial in Your Dose: Ozempic & Mounjaro Maintenance Tips”
- Linking To And Embedding Dr. Kevin Joseph’s “STOP Doing These 5 Things on Ozempic & Mounjaro”
- Linking To And Embedding Dr. Kevin Joseph’s “7 DEADLY Ozempic & Mounjaro Side Effects You MUST Know Before Starting!”
- Linking To And Embedding Dr. Kevin Joseph’s “2 Years of GLP-1 Mistakes in 7 minutes”
- Linking To And Embedding Dr. Nick Norwitz’s “Calories Don’t Cause Obesity… Yes, Really”
- American Society Of Echocardiography “ASE Guidelines”
- Mental Status Exam: A Great Template [Form] From TherapistAid.com With An Additional Resource
- Linking To And Excerpting From “Alzheimer’s Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer’s Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care”
- Linking To And Embedding Metabolic Mind And Georgia Ede MD’s “Metabolic Mailbag [3]: Ketone Plateaus, Sleep Issues, Fat Intake, and More”
- Linking To And Embedding Metabolic Mind And Georgia Ede MD’s Second Mailbag Episode “Q&A’s: Are Sweeteners Helpful or Harmful? Dairy? Ketone Levels, Longevity, and More”
- Linking To And Embedding Metabolic Mind and Georgia Ede MD’s “Q&A: Harvard Trained Psychiatrist Answers Your Mental Health and Diet Questions. Ep. 1” [Mailbag]
- Linking To And Embedding Metabolic Mind’s “Keto For Alzheimer’s: A Treatment Whose Time Has Come”
- Linking To And Embedding Dr. Nick Norwitz’s “This Will Change Your Mind on Ultra-Processed Foods (Harvard MD PhDs Discuss)”
- Linking To And Embedding Dr. Nick Norwitz’s “When Diets Collide: Mediterranean Keto – A Practical Guide”
- Linking To And Embedding Dr. Nick Norwitz’s “The Science Behind Ozempic & Other GLP-1 Medications”
- Linking To And Embedding Metabolic Mind’s “Visceral Fat And The Chronic Health Epidemic”
- Linking To And Embedding Dr. Nick Norwitz’s “The Truth About Ketone Supplements | ft’ Professor Dominic D’Agostino”
- Linking To And Embedding Dr. Nick Norwitz’ “Advances in Alzheimer’s Disease: A Deep Scientific Dive into How to Protect Your Brain”
- Linking To And Excerpting From Metabolic Mind “Ketosis and Alzheimer’s: A Metabolic Neuroscience Journey With Dr. Stephen Cunnane”
- Linking To And Embedding Metabolic Mind’s “Metabolic Mailbag: Ketone Plateaus, Sleep Issues, Fat Intake, and More”
Category Archives: COVID-19 Treatment
Links To And Excerpts From “The COVID-19 Treatment Guidelines Panel’s Statement on the Emergency Use Authorization of Casirivimab Plus Imdevimab as Post-Exposure Prophylaxis for SARS-CoV-2 Infection Last Updated: August 17, 2021” From The NIH
In this post I link to and excerpt from The COVID-19 Treatment Guidelines Panel’s Statement on the Emergency Use Authorization of Casirivimab Plus Imdevimab as Post-Exposure Prophylaxis for SARS-CoV-2 Infection. Last Updated: August 17, 2021, from The National Institutes Of … Continue reading
Posted in COVID-19, COVID-19 Treatment, Infectious Diseases
Comments Off on Links To And Excerpts From “The COVID-19 Treatment Guidelines Panel’s Statement on the Emergency Use Authorization of Casirivimab Plus Imdevimab as Post-Exposure Prophylaxis for SARS-CoV-2 Infection Last Updated: August 17, 2021” From The NIH